Literature DB >> 21936502

siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing.

Vaishali Bagalkot1, Xiaohu Gao.   

Abstract

SiRNA-aptamer chimeras are emerging as a highly promising approach for cell-type specific delivery of siRNA due to the outstanding targeting capability of aptamers and the compatibility of chimeras with native ribonuclease (Dicer) processing. For efficient RNA interference (RNAi), however, additional challenges must be addressed, in particular how to get siRNA out of the endosome after cell entry and how to preserve aptamer targeting specificity when chimeras are combined with delivery carriers. Here, we report a rationally designed nanoparticle vector that simultaneously displays large surface area for high siRNA payload, exposed aptamer for specific targeting, proton sponge effect for endosome escape, and fluorescence for imaging and quantification. A key concept of this work is to graft chimeras onto nanoparticle surface via a two-step process: first immobilizing siRNA onto nanoparticle via noncovalent interactions to facilitate intracellular unpackaging and reduce nanoparticle surface charge (avoiding nonspecific electrostatic interactions between aptamers and nanoparticles) and then coupling siRNA and aptamer with retained conformation and high accessibility. Compared with conventional one-step adsorption of siRNA-aptamer chimeras onto nanoparticles with random orientations and conformations, which does not elicit much improved RNAi effect than nontargeted nanoparticle-siRNA complexes (∼6-8% improvement of the total cell population), under the same RNA concentration our approach shows selective gene silencing and enables 34% more silenced cells of the total cell population over nontargeted nanoparticle-siRNA complexes. This remarkable difference in RNAi efficiency using nanoparticle-chimera complexes is directly related to cell uptake discrepancy resulting from aptamer conformation on the nanoparticle surface (intact vs random).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21936502      PMCID: PMC3210423          DOI: 10.1021/nn202772p

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  36 in total

Review 1.  Approaches for the sequence-specific knockdown of mRNA.

Authors:  Lisa J Scherer; John J Rossi
Journal:  Nat Biotechnol       Date:  2003-12       Impact factor: 54.908

Review 2.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

3.  Nanoparticle-mediated cellular response is size-dependent.

Authors:  Wen Jiang; Betty Y S Kim; James T Rutka; Warren C W Chan
Journal:  Nat Nanotechnol       Date:  2008-03-02       Impact factor: 39.213

4.  Layer-by-layer assembled gold nanoparticles for siRNA delivery.

Authors:  Asmaa Elbakry; Alaa Zaky; Renate Liebl; Reinhard Rachel; Achim Goepferich; Miriam Breunig
Journal:  Nano Lett       Date:  2009-05       Impact factor: 11.189

5.  Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen.

Authors:  S S Chang; V E Reuter; W D Heston; P B Gaudin
Journal:  Urology       Date:  2001-04       Impact factor: 2.649

6.  Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras.

Authors:  James O McNamara; Eran R Andrechek; Yong Wang; Kristi D Viles; Rachel E Rempel; Eli Gilboa; Bruce A Sullenger; Paloma H Giangrande
Journal:  Nat Biotechnol       Date:  2006-06-25       Impact factor: 54.908

7.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

8.  Multifunctional Quantum Dots for Personalized Medicine.

Authors:  Pavel Zrazhevskiy; Xiaohu Gao
Journal:  Nano Today       Date:  2009-10-05       Impact factor: 20.722

9.  Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

Authors:  Shawn E Lupold; Brian J Hicke; Yun Lin; Donald S Coffey
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

10.  Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol.

Authors:  Kazutaka Nishina; Toshinori Unno; Yoshitaka Uno; Takayuki Kubodera; Tadashi Kanouchi; Hidehiro Mizusawa; Takanori Yokota
Journal:  Mol Ther       Date:  2008-02-12       Impact factor: 11.454

View more
  37 in total

1.  Amphiphilic polymer-coated CdSe/ZnS quantum dots induce pro-inflammatory cytokine expression in mouse lung epithelial cells and macrophages.

Authors:  Vivian Lee; Ryan S McMahan; Xiaoge Hu; Xiaohu Gao; Elaine M Faustman; William C Griffith; Terrance J Kavanagh; David L Eaton; John K McGuire; William C Parks
Journal:  Nanotoxicology       Date:  2014-07-01       Impact factor: 5.913

Review 2.  Quantum dots-DNA bioconjugates: synthesis to applications.

Authors:  Anusuya Banerjee; Thomas Pons; Nicolas Lequeux; Benoit Dubertret
Journal:  Interface Focus       Date:  2016-12-06       Impact factor: 3.906

3.  Heme oxygenase expression as a biomarker of exposure to amphiphilic polymer-coated CdSe/ZnS quantum dots.

Authors:  Lisa A McConnachie; Collin C White; Dianne Botta; Megan E Zadworny; David P Cox; Richard P Beyer; Xiaoge Hu; David L Eaton; Xiaohu Gao; Terrance J Kavanagh
Journal:  Nanotoxicology       Date:  2012-01-20       Impact factor: 5.913

4.  Susceptibility to quantum dot induced lung inflammation differs widely among the Collaborative Cross founder mouse strains.

Authors:  David K Scoville; Collin C White; Dianne Botta; Lisa A McConnachie; Megan E Zadworny; Stefanie C Schmuck; Xiaoge Hu; Xiaohu Gao; Jianbo Yu; Russell L Dills; Lianne Sheppard; Martha A Delaney; William C Griffith; Richard P Beyer; Richard C Zangar; Joel G Pounds; Elaine M Faustman; Terrance J Kavanagh
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-21       Impact factor: 4.219

5.  Facilitated preparation of bioconjugatable zwitterionic quantum dots using dual-lipid encapsulation.

Authors:  Robert Shrake; Violeta G Demillo; Mojtaba Ahmadiantehrani; Xiaoshan Zhu; Nelson G Publicover; Kenneth W Hunter
Journal:  J Colloid Interface Sci       Date:  2014-09-21       Impact factor: 8.128

6.  A polymer encapsulation approach to prepare zwitterion-like, biocompatible quantum dots with wide pH and ionic stability.

Authors:  Liming Huang; Mingxia Liao; Siqi Chen; Violeta G Demillo; Sally A Dupre; Xiaoshan Zhu; Nelson G Publicover; Kenneth W Hunter
Journal:  J Nanopart Res       Date:  2014-08       Impact factor: 2.253

7.  Reduction Sensitive PEG Hydrogels for Codelivery of Antigen and Adjuvant To Induce Potent CTLs.

Authors:  Chintan H Kapadia; Shaomin Tian; Jillian L Perry; J Christopher Luft; Joseph M DeSimone
Journal:  Mol Pharm       Date:  2016-09-22       Impact factor: 4.939

8.  In vitro toxicity assessment of amphiphillic polymer-coated CdSe/ZnS quantum dots in two human liver cell models.

Authors:  Wesley E Smith; Jessica Brownell; Collin C White; Zahra Afsharinejad; Jesse Tsai; Xiaoge Hu; Stephen J Polyak; Xiaohu Gao; Terrance J Kavanagh; David L Eaton
Journal:  ACS Nano       Date:  2012-10-18       Impact factor: 15.881

Review 9.  Nanoplatforms for Targeted Stimuli-Responsive Drug Delivery: A Review of Platform Materials and Stimuli-Responsive Release and Targeting Mechanisms.

Authors:  Yuzhe Sun; Edward Davis
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

Review 10.  Quantum dots as a platform for nanoparticle drug delivery vehicle design.

Authors:  Christine E Probst; Pavel Zrazhevskiy; Vaishali Bagalkot; Xiaohu Gao
Journal:  Adv Drug Deliv Rev       Date:  2012-09-20       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.